second-generation TKIs
Description: Second-generation TKIs are tyrosine kinase inhibitor drugs developed to treat cancers and other diseases, including chronic myeloid leukemia and EGFR-mutated lung cancer.
Primary topic: Chronic Myeloid Leukemia Treatments (78%)
OpenAlex ID: keywords/second-generation-tkis
